Partnerships with private companies play a growing role in Seattle Children’s Research Institute’s quest to cure childhood diseases.
By developing collaborative relationships with industry, we will translate the work of our research investigators and clinicians into innovative products, devices and medical technology that will improve the lives of children and their families.
Nexgenia Collaborates with Seattle Children’s Research Institute 10.19.15 – Press Release Nexgenia, a privately held biotechnology company, is collaborating with Seattle Children’s Research Institute to develop improved immunotherapies for the treatment of cancer.
A New Model for Accelerating Translation of Pediatric Research 9.10.15 – MassBio Learn how Seattle Children’s Research Institute is moving its discoveries into the marketplace and improving outcomes for pediatric patients.
Seattle Children’s Research Institute Teams Up With bluebird bio to Pioneer Genome Editing and Gene Therapy Research in Pediatric Diseases9.10.15 – Press Release Gene therapy research aims to cure pediatric diseases early in life by targeting and repairing the disease-causing genes in a patient’s own genome.
Dr. Elizabeth Aylward, Director
818 Stewart St., Suite 603
Seattle, WA 98101
PO Box 5371
Seattle, WA 98145-5005
Meet a few of our outstanding scientists and discover their groundbreaking research in our video series.